Location

Comstock Memorial Union, MSUM

Document Type

Poster

Event Website

https://www.mnstate.edu/sac/

Start Date

23-4-2024 12:00 AM

Publication Date

April 2024

Description

Idiopathic Pulmonary Fibrosis (IPF) is a progressive and fatal lung disease that affects thousands of people worldwide. Current drugs are used in clinical settings to treat IPF but these drugs have low efficacy and a high monetary costs. The molecule antipyrine has been identified by colleagues at Mayo Clinic as an early-stage drug candidate for treatment for IPF. The Jasperse group is synthesizing analogs of antipyrine to create a drug library for improved IPF treatment. A novel three step process via a silyl enol ether intermediate has been developed to convert a C-C bond to a C=C bond between C4-C5 in previously modified analogs to better represent antipyrine. This process successfully yielded 14 novel antipyrine analogs with variations in aryl attachments. Product conversion and purity were assessed, and the final samples were around 90% or greater in purity. Relevant procedural details, NMR, GC-MS data, analog structures, and a hypothetical mechanism will be presented.

Included in

Biochemistry Commons

Share

COinS
 
Apr 23rd, 12:00 AM

Improving the Drug Antipyrine: Synthesis of N2-Aryl Analogs Through Oxidation of Dihydroantipyrines

Comstock Memorial Union, MSUM

Idiopathic Pulmonary Fibrosis (IPF) is a progressive and fatal lung disease that affects thousands of people worldwide. Current drugs are used in clinical settings to treat IPF but these drugs have low efficacy and a high monetary costs. The molecule antipyrine has been identified by colleagues at Mayo Clinic as an early-stage drug candidate for treatment for IPF. The Jasperse group is synthesizing analogs of antipyrine to create a drug library for improved IPF treatment. A novel three step process via a silyl enol ether intermediate has been developed to convert a C-C bond to a C=C bond between C4-C5 in previously modified analogs to better represent antipyrine. This process successfully yielded 14 novel antipyrine analogs with variations in aryl attachments. Product conversion and purity were assessed, and the final samples were around 90% or greater in purity. Relevant procedural details, NMR, GC-MS data, analog structures, and a hypothetical mechanism will be presented.

https://red.mnstate.edu/sac/2024/cshe/6

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.